256 Newsroom — Uganda's Digital News Infrastructure
Business

Regenxbio gene therapy refiling plan derailed by FDA hold over spine MRI findings - Fierce Biotech

Published by FierceBiotech By Nick Paul Taylor · 24 August 2026 at 14:51
Share
Regenxbio gene therapy refiling plan derailed by FDA hold over spine MRI findings - Fierce Biotech
Image · FierceBiotech

What the report says

The FDA has put a clinical hold on Regenxbio’s RGX-121 over asymptomatic spine MRI findings,

Read the full report at FierceBiotech →

Loading debate for this article…

Other publishers covering this story

No additional verified coverage is currently clustered with this report.

More stories by this journalist

Other publications from this journalist — open any story without leaving the article page.

No other published stories from this publisher yet.

Related reporting

King Oyo buried as Omusuuga reaffirms new monarchThe Observer Thousands mourn King Oyo at funeral ceremony in Fort PortalThe Independent Uganda 256 Newsroom 256Shield gives institutions a practical way to see, test and manage cyber risk256Shield 256 Newsroom Busoga eyes coffee, cocoa tourism to create jobs - Daily MonitorDaily Monitor Ugandan farmers count heavy losses as drought withers crops, weakens livestockThe Independent Uganda Spiro Partners With Yadea to Scale Electric Mobility Across AfricaNile Post